Shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) have been given a consensus rating of “Buy” by the nineteen brokerages that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have assigned a buy rating to the company. […]
DexCom, Inc. (NASDAQ:DXCM – Get Rating) – Stock analysts at William Blair boosted their Q3 2022 earnings per share estimates for shares of DexCom in a research note issued to investors on Thursday, April 28th. William Blair analyst M. Kaczor now forecasts that the medical device company will post earnings per share of $1.05 for […]
/PRNewswire/ Biosensors market value projected to reach USD 43 billion by 2028, according to a new research report by Global Market Insights Inc. Expanding.
DexCom, Inc. (NASDAQ:NASDAQ:DXCM) Q1 2022 Earnings Conference Call April 28, 2022 17:30 ET Company Participants Sean Christensen - Investor Relations Kevin Sayer - Chairman, President and.